|
ACTU Actuate Therapeutics Inc 1652935 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-4,866,635.00 |
| Balance Sheet |
|
Current Assets
|
$4,747,941.00 |
|
Assets
|
$5,199,339.00 |
|
Current Liabilities
|
$3,805,196.00 |
|
Liabilities
|
$4,210,187.00 |
|
Equity
|
$989,152.00 |
|
Shares Out
|
24013577.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-9,422,450.00 |
| Market Analysis |
Market Cap
|
$29,536,699.71 |
|
Price
|
$0.98 |
|
BVPS
|
0.04 |
|
PB
|
30.75 |
|
EPS
|
-0.20 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:54 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:45 |
|
| Apr |
May |
Jun |
| 2026-03-26 |
-1.06 |
|
|
2026-05-14 |
-0.24 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.25 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ACTU documents filed with the SEC.
ACTU Filings
Clear
